pI: 5.1172 |
Length (AA): 391 |
MW (Da): 41676 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
97 | 385 | 1a6q () | 3 | 298 | 26.00 | 0 | 1 | 1.08 | -0.7 |
2 | 133 | 4k6j (A) | 740 | 878 | 8.00 | 0 | 0.01 | 0.451796 | -0.52 |
99 | 385 | 4rag (A) | 5 | 298 | 23.00 | 0.0000000058 | 1 | 0.965515 | -0.05 |
106 | 380 | 3rt0 (B) | 180 | 503 | 31.00 | 0 | 1 | 0.897525 | -0.73 |
114 | 377 | 2p8e (A) | 20 | 294 | 32.00 | 0 | 1 | 1.07639 | -0.71 |
115 | 378 | 1txo (A) | 7 | 238 | 22.00 | 0 | 1 | 0.785392 | 0.01 |
119 | 380 | 3nmv (B) | 114 | 413 | 38.00 | 0 | 1 | 0.992677 | -0.52 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_132000)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G43900 | putative protein phosphatase 2C 11 |
Brugia malayi | Bm1_05515 | Protein phosphatase 2C containing protein |
Caenorhabditis elegans | CELE_T19C3.8 | Protein FEM-2 |
Drosophila melanogaster | Dmel_CG10376 | CG10376 gene product from transcript CG10376-RA |
Entamoeba histolytica | EHI_200680 | protein phosphatase domain-containing protein |
Homo sapiens | ENSG00000175175 | protein phosphatase, Mg2+/Mn2+ dependent, 1E |
Leishmania braziliensis | LbrM.20.2040 | protein phosphatase 2C-like protein |
Leishmania donovani | LdBPK_342310.1 | protein phosphatase 2C-like protein |
Leishmania infantum | LinJ.34.2310 | protein phosphatase 2C-like protein |
Leishmania major | LmjF.34.2500 | protein phosphatase 2C-like protein |
Leishmania mexicana | LmxM.33.2500 | protein phosphatase 2C-like protein |
Mus musculus | ENSMUSG00000046442 | protein phosphatase 1E (PP2C domain containing) |
Oryza sativa | 4341949 | Os06g0698300 |
Oryza sativa | 4328306 | Os02g0149800 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3
15 literature references were collected for this gene.